Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes.
Sameer Farouk SaitNancy A KernanElizabeth KleinBarbara SpitzerCarolyn Fein LevyJonathan D FishOnur YildrimSofia HaqueMaria DonzelliMauricio Rendon BernotDavid H AbramsonJasmine H FrancisYasmin KhakooMatthias A KarajannisStephen A SandsNeeta Pandit-TaskarSuzanne L WoldenKim KramerIra J DunkelPublished in: Pediatric blood & cancer (2024)
CSI (23.4 Gy) alone or in conjunction with intraventricular RIT may have clinical utility in eliminating persistent MRD post HDC-ASCT, contributing to improved disease-free survival in patients with CNS RB. This treatment strategy merits evaluation in a prospective, multicenter clinical trial for patients with CNS metastatic RB.
Keyphrases